Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | ACHE | P22303 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | SYK | P43405 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29367415 | 1.00 | ALDH1A1 (0.39) | ALDH1A1CA2ACHEPOLBTYR | |
| SCHEMBL8778870 | 0.91 | SMN1; SMN2 (0.37) | ALDH1A1CA2ACHEPOLBTYR | |
| SCHEMBL12861911 | 0.91 | TSHR (0.45) | ALDH1A1CA2ACHEPOLBTYR | |
| SCHEMBL6166148 | 0.88 | MEN1 (0.34) | ALDH1A1CA2ACHEPOLBTYR | |
| SCHEMBL1160297 | 0.88 | MEN1 (0.34) | ALDH1A1CA2ACHEPOLBTYR | |
| SCHEMBL11268124 | 0.87 | ACHE (0.46) | ALDH1A1CA2ACHESMN1; SMN2MEN1 | |
| SCHEMBL2775176 | 0.85 | ALDH1A1 (0.41) | ALDH1A1CA2ACHEPOLBTYR | |
| SCHEMBL7948551 | 0.85 | USP2 (0.36) | ALDH1A1CA2ACHEPOLBTYR | |
| SCHEMBL5960888 | 0.85 | USP2 (0.36) | ALDH1A1CA2ACHEPOLBTYR | |
| SCHEMBL11262011 | 0.85 | ALDH1A1 (0.41) | ALDH1A1CA2ACHEPOLBTYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 922 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119425795-A | Catalyst for hydroformylation of olefins and process for preparing isovaleraldehyde | 宁夏天新药业有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-114057558-B | Synthesis method, catalytic system and application of 3, 5-trimethylhexanal | 上海簇睿低碳能源技术有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-109311002-B | Catalyst composition for hydroformylation reaction and method for preparing aldehyde using the same | LG化学株式会社 | 2021-12-10 | — | — | CN | claimed |
| CN-108047013-B | Synthetic method of isopentenal | 万华化学集团股份有限公司 | 2020-11-24 | — | — | CN | claimed |
| EP-3156127-B1 | CATALYTIC COMPOSITION CONTAINING PHOSPHORUS-BASED LIGAND AND METHOD FOR HYDROFORMYLATION USING SAME | LG CHEMICAL LTD (KR) | 2019-07-31 | — | — | EP | claimed |
| US-9707552-B1 | Catalyst composition comprising phosphorus-based ligand and hydroformylation process using the same | LG CHEM. LTD. (KR) | 2017-07-18 | — | — | US | claimed |
| US-20170197201-A1 | CATALYST COMPOSITION COMPRISING PHOSPHORUS-BASED LIGAND AND HYDROFORMYLATION PROCESS USING THE SAME | LG CHEM, LTD. (KR) | 2017-07-13 | — | — | US | claimed |
| EP-3156127-A1 | CATALYTIC COMPOSITION CONTAINING PHOSPHORUS-BASED LIGAND AND METHOD FOR HYDROFORMYLATION USING SAME | LG Chem, Ltd. (KR) | 2017-04-19 | — | — | EP | claimed |
| US-8183311-B2 | Liquid phosphite composition derived from cresols | CHEMTURA CORPORATION (US) | 2012-05-22 | — | — | US | claimed |
| WO-2011014211-A1 | LIQUID PHOSPHITE COMPOSITION DERIVED FROM META-CRESOLS | CHEMTURA CORPORATION (US) | 2011-02-03 | — | — | WO | claimed |
| EP-0254348-A2 | Process of (co)polymerization of alpha-olefins in the presence of antioxidants | ENICHEM SYNTHESIS S.p.A. (IT) | 1988-01-27 | — | — | EP | claimed |
| US-4670489-A | PHOTOSTABILIZERS FOR PAINTS, RESINS | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 1987-06-02 | — | — | US | claimed |
| EP-0028123-B1 | SPECTROPHOTOMETRIC METHOD FOR THE DETERMINATION OF TOTAL BILIRUBIN | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1984-12-12 | — | — | EP | claimed |
| US-4467116-A | Process for the hydroformylation of olefins | SHELL OIL COMPANY (US) | 1984-08-21 | — | — | US | claimed |
| US-4360617-A | HEAT RESISTANT POLYMER | CIBA-GEIGY CORPORATION (US) | 1982-11-23 | — | — | US | claimed |
| US-4348308-A | IMPROVING COLOR STABILITY OF VINYL CHLORIDE POLYMERS | ADEKA ARGUS CHEMICAL CO., LTD. (JP) | 1982-09-07 | — | — | US | claimed |
| EP-0054986-A1 | A process for the hydroformylation of olefins | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1982-06-30 | — | — | EP | claimed |
| US-4309335-A | THERMAL AGING RESISTANCE; ORTHO-SUBSTITUTED PHENYL ACID PHOSPHITE | ADEKA ARGUS CHEMICAL CO., LTD. | 1982-01-05 | — | — | US | claimed |
| US-4290941-A | ANTIOXIDANTS | CIBA-GEIGY CORPORATION (US) | 1981-09-22 | — | — | US | claimed |
| US-4187212-A | Stabilization systems from triarylphosphites and phenols | CIBA-GEIGY CORPORATION (US) | 1980-02-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170197201-A1 | CATALYST COMPOSITION COMPRISING PHOSPHORUS-BASED LIGAND AND HYDROFORMYLATION PROCESS USING THE SAME | NUDT1, PPIP5K2, ITPA | ALDH1A1 663/4885CA2 2214/4885ACHE 1329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.